Gauss Surgical, a medical device company, has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery
Stryker has completed the acquisition of Gauss Surgical. Headquartered in Menlo Park, CA, Gauss Surgical is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Triton has demonstrated improvements in maternal and surgical care through earlier recognition of haemorrhage leading to earlier intervention.
“Gauss Surgical’s innovative Triton technology will help fill the void of quantifying blood loss to enable accuracy, early detection of haemorrhage and prevention of maternal morbidity,” said Dylan Crotty, President, Stryker’s Instruments division. “We believe that Triton technology will help improve the industry standards for quantifying blood loss in the labour and delivery department, furthering Stryker’s commitment to improving safety and outcomes for our caregivers and their patients.”
“Since the advent of modern surgery, visual estimation of blood loss has remained a notoriously inaccurate and imprecise standard of care,” said Siddarth Satish, CEO and Founder, Gauss Surgical. “I am excited to expand this offering with Stryker.”